Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Progress in mitochondrial replacement therapies

Nature Reviews Molecular Cell Biology volume 19, pages 71–72 (2018)Cite this article

Subjects

Abstract

Mitochondrial DNA is maternally inherited, and pathogenic mutations cause a range of life-limiting conditions. Recent studies indicate that transmission of pathogenic mutations may be prevented by reproductive technologies designed to replace the mitochondria in eggs from affected women.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Gorman, G. S. et al. Mitochondrial diseases. Nat. Rev. Dis. Primers 2, 16080 (2016).

    Article  Google Scholar 

  2. Suomalainen, A. & Battersby, B. J. Mitochondrial diseases: the contribution of organelle stress responses to pathology. Nat. Rev. Mol. Cell Biol. https://doi.org/10.1038/nrm.2017.66 (2017).

    Article  Google Scholar 

  3. Greenfield, A., Braude, P., Flinter, F. & Lovell-Badge, R. Assisted reproductive technologies to prevent human mitochondrial disease transmission. Nat. Biotechnol. 35, 1059–1068 (2017).

    Article  CAS  Google Scholar 

  4. Ma, H. et al. Functional human oocytes generated by transfer of polar body genomes. Cell Stem Cell 20, 112–119 (2017).

    Article  CAS  Google Scholar 

  5. Eyre-Walker, A. Mitochondrial replacement therapy: are mito-nuclear interactions likely to be a problem? Genetics 205, 1365–1372 (2017).

    Article  Google Scholar 

Download references

Acknowledgements

Work in the authors' laboratories is funded by grants from The Wellcome Centre for Mitochondrial Research, Medical Research Council, EU Horizon 2020 and the UK NIHR Biomedical Research Centre awarded to Newcastle upon Tyne NHS Trust.

Author information

Authors and Affiliations

  1. Wellcome Centre for Mitochondrial Research, Institute of Genetic Medicine and Institute of Neurosciences, Newcastle University, Newcastle upon Tyne, UK

    Mary Herbert & Doug Turnbull

Authors
  1. Mary Herbert
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Doug Turnbull
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Mary Herbert or Doug Turnbull.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Herbert, M., Turnbull, D. Progress in mitochondrial replacement therapies. Nat Rev Mol Cell Biol 19, 71–72 (2018). https://doi.org/10.1038/nrm.2018.3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrm.2018.3

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing